NACFC 2019

Vertex Presents Data at the North American Cystic Fibrosis Conference (NACFC)

England Announcement

Vertex Announces Agreement with NHS England for Access to Licensed Cystic Fibrosis Medicines

Triple Announcement

U.S. FDA Approves Our Fourth CF Medicine

Biotechnology to Create Transformative Medicines

At Vertex, we're relentless in our pursuit of medical research to create transformative medicines for people with serious and life-threatening diseases, like cystic fibrosis.

pipeline and medicine

Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases.

working here

At Vertex, we have some of the industry's best and brightest people helping us achieve our mission of discovering transformative medicines to help people with serious diseases, like cystic fibrosis. 


U.S. FDA Approves Our Fourth CF Medicine

Follow Us for Updates